Olympus 2014 Annual Report Download - page 16

Main Areas and ProductsBusiness Segment Net SalesResults of Operations (2014/3) Operating Income (Loss) /
Operating Margin
Share of Net Sales Share of Net Sales
by Region
69.0%
Others
3.1%
Asia /
Oceania
16.6%
13.8%
13.5%
Company History
In order to concentrate the allocation of management resources to business domains, we
followed up the September 2012 transference of the Information & Communication Business
by withdrawing from the biologics business in February 2014. We also proceeded with the
sale and liquidation of several subsidiaries from which we could not expect synergistic bene-
fi ts with core businesses. As a result, net sales in the Others segment declined 37%, to ¥26.4
billion. Operating loss in this segment came to ¥5.4 billion, but we expect to break even in
fi scal 2015 and beyond due to the benefi ts of withdrawing from the biologics business.
Others
Europe
25.8%
North
America
30.3%
Japan
24.2%
At a Glance
3.7%
1919
Established as
Takachiho Seisakusho
to manufacture micro-
scopes in Japan
1936
Semi-Olympus I, the fi rst
Olympus camera intro-
duced, marking entry
into camera business
1920
Asahi 600x microscope
introduced
1975
Entry into medical
surgical endoscopy field
1949
Name changed
to Olympus Optical
Co., Ltd.
The Company listed
on the TSE
1996
Entry into digital camera
business
1950
Development of the
world’s fi rst practical
gastrocamera
1968
Entry into industrial
endoscope field
2008
Acquisition of Gyrus
Group PLC to strengthen
surgical area of Medical
Business
2009
Olympus launches its
fi rst mirrorless inter-
changeable lens camera,
OLYMPUS PEN E-P1
1969
The world’s fi rst micro-
cassette tape recorder
developed
29
OLYMPUS Annual Report 2014
28 OLYMPUS Annual Report 2014
Gastrointestinal Endoscopes
Endoscopy systems (videoscopes, video processors,
light sources, liquid crystal display (LCD) panels);
Peripheral equipment (image recording device,
endoscope cleaning systems, sterilization systems), etc.
Surgical Devices
Surgical video endoscopy systems, peripheral devices
for endoscopic surgery, electrosurgical knives, etc.
Endotherapy Devices
Endoscopic devices for all disciplines of endoscopy
(approximately 1,000 different devices for various
diagnostic and treatment procedures, including biopsy
forceps, high-frequency polypectomy snares, grasping
forceps, stone retrieval and lithotriptor baskets,
hemostasis accessories, etc.)
Life Science
Upright microscopes and polarizing microscopes,
inverted microscopes, laser confocal microscopes,
box-type fl uorescence imaging devices, stereo
microscopes, fl uorescence macromicroscopes,
microscope digital cameras, imaging software,
bio-imaging systems, virtual slide systems
Industrial
Metallurgical microscopes, semiconductor inspection
microscopes, laser microscopes, measuring
microscopes, microscopic 3D measurement systems,
industrial videoscopes, industrial fi berscopes, industrial
rigid scopes, ultrasonic fl aw detectors, eddy current fl aw
detectors, phased array fl aw detectors, X-ray diffraction
analyzers, peripheral equipment
Digital Cameras
Digital single-lens cameras, compact digital cameras,
digital camera related products, digital camera lens
barrels, optical components
Others
IC recorders, binoculars
In the gastrointestinal endoscope fi eld,
sales of gastrointestinal video endoscopy
systems launched during fi scal 2013
madelarge contributions to earnings. In
the surgical device fi eld, domestic and
overseas sales were up for surgical endos-
copy systems. As a result, net sales in the
Medical Business were ¥492.3 billion, up
25% year on year, and operating income
totaled ¥112.7 billion, up 30%. Both
fi gures represented new record highs.
In the life science fi eld, we introduced new
products, such as laser scanning micro-
scopes. New offerings in the industrial fi eld
included industrial videoscopes and ultra-
sonic fl aw detectors. These new products
sold favorably, driving a 15% year-on-year
increase in net sales, to ¥98.5 billion,
and a 40% rise in operating income,
to ¥4.9 billion.
Net sales in the focus area of mirrorless
cameras increased 13% year on year
following the expansion of our lineup of
strategic OM-D series products. Overall,
net sales in the Imaging Business were
down 11% because we accelerated
the shift to mirrorless cameras and
reduced compact camera sales volumes.
Regardless, operating loss decreased
substantially as a result of lower costs.
Medical Business
Scientific Solutions
Business
Imaging Business
–30
–20
–10
0
10
2012/3 2013/3 2014/3
(¥ Billion)
2015/3
(Forecast)
(3.5)
(10.8)
(23.1)
(9.2)
2012/3 2013/3 2014/3
0
50
100
150
(¥ Billion)
2015/3
(Forecast)
128.6
107.6
96.1 97.0
115.2
13.3
95.1
12.5
83.6
12.5
79.5
17.5
Digital cameras Others Operating loss
(¥ Billion)
2012/3 2013/3 2014/3 2015/3
(Forecast)
0
200
400
600
349.2
394.7
492.3
540.0
191.8
157.4
218.7
176.1
274.0
218.3
294.5
245.5
2012/3 2013/3 2014/3
0
50
100
150
(%)
0
5
10
15
20
25
(¥ Billion)
2015/3
(Forecast)
87.1
68.2
19.5
22.1
112.7
22.9
115.0
21.3
Endoscopes Surgical & endotherapy devices Operating income Operating margin (right)
2012/3 2013/3 2014/3
0
40
80
120
(¥ Billion)
2015/3
(Forecast)
92.4 85.5
98.5 104.0
42.7
49.8
38.9
46.6
44.8
53.7
47.1
56.9
Life science Industrial
2012/3 2013/3 2014/3
(%)
0
5
10
15
(¥ Billion)
2015/3
(Forecast)
0
2
4
6
8
10
5.4
3.5
4.9 4.5
4.3
5.9
4.1
5.0
Operating income Operating margin (right)